Abstract:1377 Objectives Small interfering RNA (siRNA) tumor imaging and therapies administered by intravenous injection require a highly efficient delivery system to perform the function of gene silencing. The overall purpose of this study was to develop and characterize a novel integrin αvβ3-specific delivery vector for improving transfection of siRNA in malignant tumors in vitro. Methods For specific siRNA delivery to tumor cells, we adopted a cyclic Arg-Gly-Asp (RGD) peptide as a promising molecule for recognition of tumor tissues expressing integrin ανβ3. To enable siRNA binding, a chimaeric peptide was synthesized by adding nonamer arginine residues (9R) at the carboxy terminus of cyclic-RGD dimer, designated as c(RGD)2-9R. To verify the combination of c(RGD)2-9R with siRNA, electrophoresis on 2% agarose gels was performed. The stability of c(RGD)2-9R/siRNA in different conditions were confirmed by electrophoresis. The efficiency of c(RGD)2-9R peptides transferring siRNA was evaluated in vitro by the methods of flow cytometry and confocal microscopy. All data were analyzed with the statistical software SPSS17.0, and a value of P less than 0.05 was considered to be statistically significant. Results The peptide of c(RGD)2-9R was able to bind siRNA in a dose-dependent manner. An optimal 10:1 molar ratio of c(RGD)2-9R to siRNA was confirmed. The complex of c(RGD)2-9R/siRNA remained stable and complete at room temperature and in fresh 37oC human serum, even after 72h. The results of flow cytometry showed that the average siRNA transfection efficiencies of c(RGD)2-9R and liposome were 61.0%±13.4% and 91.5%±1.84%, respectively, which were all much higher than that of FAM-siRNA alone (8.08%±6.45%) (P Conclusions The chimaeric peptide of c(RGD)2-9R is considered to be an effective siRNA delivery vector in vitro, and a hopeful application in vivo needs further examination.

Tumor-Targeted In Vivo Gene Silencing Via Systemic Delivery Of Crgd-Conjugated Sirna

Tumor-Targeted Anti-VEGF RNAi Capable of Sequentially Responding to Intracellular Microenvironments for Potent Systemic Tumor Suppression.

Systemic and Tumor-Targeted Delivery of Sirna by Cyclic NGR and Isodgr Motif-Containing Peptides.

Construction and Characterization of Crgd-Modified 9-Arginine Peptide As A Novel Vector for Targeted Sirna Delivery

Systemic Administration of Sirna Via Crgd-Containing Peptide

Targeted Gene Silencing Using Rgd-Labeled Chitosan Nanoparticles

Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.

In Vitro and in Vivo Therapeutic Sirna Delivery Induced by a Tryptophan-Rich Endosomolytic Peptide

An RGD-modified MRI-visible Polymeric Vector for Targeted Sirna Delivery to Hepatocellular Carcinoma in Nude Mice.

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery

In Vivo Tumor Targeting Via Nanoparticle-Mediated Therapeutic Sirna Coupled to Inflammatory Response in Lung Cancer Mouse Models

Data from Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles

Tumor-specific Delivery of KRAS Sirna with Irgd-Exosomes Efficiently Inhibits Tumor Growth

Sirna and Chemotherapeutic Molecules Entrapped into a Redox-Responsive Platform for Targeted Synergistic Combination Therapy of Glioma.

Bioreducible, Arginine-Rich Polydisulfide-Based Sirna Nanocomplexes with Excellent Tumor Penetration for Efficient Gene Silencing.

Tumor specific delivery with redox-triggered mesoporous silica nanoparticles inducing neovascularization suppression and vascular normalization

Noninvasive Imaging of C(Rgd)(2)-9r As A Potential Delivery Carrier for Transfection of Sirna in Malignant Tumors

Reductive Nanocomplex Encapsulation of Crgd-Sirna Conjugates for Enhanced Targeting to Cancer Cells.

Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying Both Ligand and Sirna

Ultra‐pH‐Responsive and Tumor‐Penetrating Nanoplatform for Targeted Sirna Delivery with Robust Anti‐Cancer Efficacy

Worm-Like Biomimetic Nanoerythrocyte Carrying Sirna for Melanoma Gene Therapy